- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 38/29 - Parathyroid hormone, i.e. parathormoneParathyroid hormone-related peptides
Patent holdings for IPC class A61K 38/29
Total number of patents in this class: 492
10-year publication summary
|
24
|
31
|
33
|
37
|
36
|
36
|
30
|
43
|
34
|
29
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Radius Health, Inc. | 96 |
34 |
| Ascendis Pharma Bone Diseases A/S | 48 |
31 |
| Entera Bio Ltd. | 47 |
27 |
| Rani Therapeutics, LLC | 200 |
27 |
| MannKind Corporation | 520 |
19 |
| Asahi Kasei Pharma Corporation | 129 |
16 |
| Board of Trustees of the University of Arkansas | 824 |
12 |
| Purdue Research Foundation | 3715 |
9 |
| National University Corporation Kagawa University | 210 |
9 |
| The General Hospital Corporation | 4793 |
8 |
| Kindeva Drug Delivery L.P., Kindeva GP II LLC, a Delaware limited liability company | 217 |
8 |
| Ipsen Pharma S.A.S. | 372 |
6 |
| Montefiore Medical Center | 82 |
6 |
| Ochsner Clinic Foundation | 26 |
6 |
| University of Rochester | 1320 |
6 |
| Amryt Endo, Inc. | 52 |
6 |
| Eli Lilly and Company | 3892 |
5 |
| The Kitasato Institute | 157 |
5 |
| Mondobiotech Laboratories AG | 311 |
5 |
| TOLMAR International Limited | 87 |
5 |
| Other owners | 242 |